TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,367 | +14.3% | 11,333 | +101.5% | 0.00% | -33.3% |
| Q2 2020 | $374,000 | -2.6% | 5,623 | -10.4% | 0.00% | 0.0% |
| Q1 2020 | $384,000 | -24.4% | 6,275 | +8.7% | 0.00% | -25.0% |
| Q4 2019 | $508,000 | -9.9% | 5,775 | -22.7% | 0.00% | 0.0% |
| Q3 2019 | $564,000 | +4.8% | 7,475 | +18.7% | 0.00% | +33.3% |
| Q2 2019 | $538,000 | -28.4% | 6,300 | -9.4% | 0.00% | -40.0% |
| Q1 2019 | $751,000 | -6.8% | 6,950 | -27.0% | 0.01% | 0.0% |
| Q4 2018 | $806,000 | -38.9% | 9,525 | -29.1% | 0.01% | -28.6% |
| Q3 2018 | $1,320,000 | -10.5% | 13,425 | +5.3% | 0.01% | -12.5% |
| Q2 2018 | $1,475,000 | +98.5% | 12,750 | +150.0% | 0.01% | +60.0% |
| Q2 2016 | $743,000 | – | 5,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |